Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Laboratoire Modilac – Groupe SavenciaLaboratoire Modilac – Groupe Savencia
VS
AUROBINDO PHARMA LTDAUROBINDO PHARMA LTD
Laboratoire Modilac – Groupe Savencia

Laboratoire Modilac – Groupe Savencia

68 rue de Villiers, Levallois Perret, 92532, FR

Last Update: 27/02/2026

View Profile
Between 750 and 799
http://www.modilac.fr
753/1000Fair

Laboratoire Modilac est spécialisé en nutrition infantile. La marque Laboratoire Modilac est commercialisée en pharmacie et en GMS. Depuis plus de 40 ans, nous contribuons activement à l’évolution de la nutrition infantile et au développement de formules très innovante...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:117
Subsidiaries:25
12-month incidents
0
Known data breaches
0
Attack type number
0
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District,, Hyderabad, 500032, IN

Last Update: 13/09/2026

View Profile
Between 750 and 799
https://www.aurobindo.com/
781/1000Fair

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, brand...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,862
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Laboratoire Modilac – Groupe Savencia

Laboratoire Modilac – Groupe Savencia

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Laboratoire Modilac – Groupe Savencia in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for AUROBINDO PHARMA LTD in 2026.

Incidents

Incident History - Laboratoire Modilac – Groupe Savencia (X = Date, Y = Severity)

Laboratoire Modilac – Groupe Savencia cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - AUROBINDO PHARMA LTD (X = Date, Y = Severity)

AUROBINDO PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Laboratoire Modilac – Groupe Savencia

Laboratoire Modilac – Groupe Savencia

Incidents
No explicit notable incidents reported.
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

Incidents
No explicit notable incidents reported.

FAQ

Between Laboratoire Modilac – Groupe Savencia company and AUROBINDO PHARMA LTD company, which one has the best AI Cybersecurity Score ?
Between Laboratoire Modilac – Groupe Savencia company and AUROBINDO PHARMA LTD company, which one has experienced more cyber incidents in the past ?
Between Laboratoire Modilac – Groupe Savencia company and AUROBINDO PHARMA LTD company, which one has experienced more cyber incidents this year ?
Between Laboratoire Modilac – Groupe Savencia company and AUROBINDO PHARMA LTD company, which one has experienced at least one ransomware attack ?
Between Laboratoire Modilac – Groupe Savencia company and AUROBINDO PHARMA LTD company, which one has experienced at least one data breach ?
Between Laboratoire Modilac – Groupe Savencia company and AUROBINDO PHARMA LTD company, which one has experienced at least one targeted cyberattack ?
Between Laboratoire Modilac – Groupe Savencia company and AUROBINDO PHARMA LTD company, which one has experienced at least one vulnerability ?
Between Laboratoire Modilac – Groupe Savencia company and AUROBINDO PHARMA LTD company, which one holds the most compliance certifications ?
Between Laboratoire Modilac – Groupe Savencia company and AUROBINDO PHARMA LTD company, which one holds the fewest compliance certifications ?
Between Laboratoire Modilac – Groupe Savencia company and AUROBINDO PHARMA LTD company, which one has the most subsidiaries ?
Between Laboratoire Modilac – Groupe Savencia company and AUROBINDO PHARMA LTD company, which one has the largest number of employees ?
Between Laboratoire Modilac – Groupe Savencia and AUROBINDO PHARMA LTD, which company holds both SOC 2 Type 1 certifications ?
Between Laboratoire Modilac – Groupe Savencia and AUROBINDO PHARMA LTD, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Laboratoire Modilac – Groupe Savencia or AUROBINDO PHARMA LTD ?
Which company is PCI DSS compliant - Laboratoire Modilac – Groupe Savencia or AUROBINDO PHARMA LTD ?
Between Laboratoire Modilac – Groupe Savencia and AUROBINDO PHARMA LTD, which company complies with HIPAA regulations for healthcare data ?
Between Laboratoire Modilac – Groupe Savencia and AUROBINDO PHARMA LTD, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-102335
SUMMARY

Nginx Proxy Manager through 2.16.0 fails to restrict the advanced_config field to administrators, allowing non-admin users with manage permissions to inject arbitrary nginx directives. Attackers can inject malicious nginx configuration such as alias directives to serve arbitrary files or control routing for their assigned hosts.

PUBLISHED
Date2026-09-28
UPDATED
Date2026-09-28
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4.2
EXPLOITABILITY
2.8
CVE-2026-102334
SUMMARY

Nginx Proxy Manager through 2.16.0 lacks rate-limiting on authentication endpoints, allowing unauthenticated attackers to make unlimited password guesses against any account. Attackers can brute-force login credentials via POST /api/tokens and subsequently guess TOTP codes via POST /api/tokens/2fa to gain full session access and administrative control.

PUBLISHED
Date2026-09-28
UPDATED
Date2026-09-28
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
CVSS4
Base Score: 9.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
2.2
CVE-2026-102333
SUMMARY

httpdbg before 2.2.1 fails to validate URL schemes in recorded HTTP request URLs rendered as clickable links in the web interface. Attackers controlling traffic recorded by httpdbg can supply javascript: scheme URLs that execute malicious scripts in the application origin when clicked, allowing access to captured request and response data including headers and tokens.

PUBLISHED
Date2026-09-28
UPDATED
Date2026-09-28
RISK INFORMATION (Score: 6.1)
CVSS3
Base Score: 6.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
2.7
EXPLOITABILITY
2.8
CVE-2026-102332
SUMMARY

Dozzle versions before 11.1.2 fail to sanitize container display names when building ZIP archive entry names in the log download endpoint. Attackers who can label containers can use path traversal sequences to write files outside the extraction directory when users download and extract logs.

PUBLISHED
Date2026-09-28
UPDATED
Date2026-09-28
RISK INFORMATION (Score: 6.1)
CVSS3
Base Score: 6.1
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:C/C:N/I:H/A:N
CVSS4
Base Score: 4.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:A/VC:N/VI:N/VA:N/SC:N/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4
EXPLOITABILITY
1.6
CVE-2026-101262
SUMMARY

A vulnerability has been found in Ziroom ZHOME A0101 1.0.1.0. This vulnerability affects unknown code of the file /api/ZRQos/set_online_client. The manipulation of the argument ip leads to command injection. It is possible to initiate the attack remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-28
UPDATED
Date2026-09-28
RISK INFORMATION (Score: 9.1)
CVSS2
Base Score: 8.3
Complexity: LOW
AV:N/AC:L/Au:M/C:C/I:C/A:C
CVSS3
Base Score: 9.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 8.5
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
2.3